Intelligence / Healthtech / New Clinical Trials / Efferon JSC
Clinicaltrial registered22 Oct 2026
Efferon JSC
22 Oct 2026: Trial registered · Quality of Life in Patients With Post-Sepsis Syndrome. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 22 Oct 2026
- Title
- Quality of Life in Patients With Post-Sepsis Syndrome
- Conditions
- Sepsis
- Study Type
- Observational
- Status
- Not Yet Recruiting
- Countries
- Russia
- Country
- Russia
- Reference
- NCT07889804
- Location
- Russia
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Efferon JSC
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
More from Russia
New Clinical Trials
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.